-

Atropos Health Scales Federated Evidence Network with Multimodal Data Partners to Accelerate Health Analytics and AI Model Development

Enhanced network coverage unlocks broader clinical insights and streamlined data access across healthcare, life sciences, and technology platforms

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, a leader in real-world evidence (RWE) generation from high-quality healthcare data, today announced a significant expansion of its federated Atropos Evidence™ Network. The expansion includes deeper collaborations with Norstella and Arcadia, along with new data partnership agreements with OneMedNet Corporation (Nasdaq: ONMD).

These alliances extend the scope of Atropos Health’s data ecosystem across clinical decision support (CDS), model training, and benchmark development, delivering precision insights to power modern medicine.

Comprising dozens of primary and aggregated data sources, the federated network now covers:

  • National Reach: Over 330 million U.S. patients
  • Claims Coverage: Scaled open and closed claims
  • EHR Integration: 150 million+ patient EHR records, including clinical notes for regulatory-grade RWE applications
  • Multimodal Data: Imaging and omics data linked directly to clinical outcomes and mortality datasets
  • Privacy-first Linkage: Advanced cross-source linkage leveraging proprietary de-identification technology

This expanded scale powers critical applications across life sciences, health systems, and technology platforms, including:

  • RWE and Observational Research Generation: Regulatory-grade studies incorporating clinical notes, omics, and imaging datasets
  • Health Economics & Outcomes Research (HEOR): Advanced cost and utilization analyses driving budget impact and economic modeling
  • Rapid Commercial Analytics: On-demand market intelligence covering prescription trends, therapy switching, physician behavior, and commercial targeting
  • AI & Predictive Model Training: Algorithmic development to identify rare/undiagnosed patient populations and set model performance benchmarks

Through collaborative integrations with Norstella, Arcadia, and OneMedNet, Atropos Evidence Network users can seamlessly move beyond static data retrieval to generate proactive, on-demand evidence and insights in seconds.

“We are moving medicine toward a future where precision evidence guides every healthcare decision, and that requires embedding evidence capabilities directly into the tools researchers and clinicians use every day,” said Dr. Brigham Hyde, CEO and Co-Founder of Atropos Health. “Incorporating de-identified multimodal data into the Atropos Evidence Network provides the deeper clinical context necessary to fuel healthcare innovation.”

Activating Trustworthy Real-World Insights

Integrating Atropos Health tools allows partner platforms to run complex temporal queries up to 50 times faster and 30 times more cost-effectively than traditional data analytics methods. All integrated solutions leverage Atropos Health’s Real World Fitness Score® (RWFS), an automatic grading framework that evaluates data quality and fitness for specific clinical questions to ensure unmatched trust and transparency.

“This partnership perfectly exemplifies our strategy: transforming our unique, Direct from Source, regulatory decision-grade data into long-term subscription collaborations that put our data directly into our partners’ hands — removing the friction that has traditionally slowed access to high-quality Real-World Data,” said Aaron Green, President & CEO of OneMedNet. “Atropos sets the standard for rapid, personalized evidence, and we strengthen the foundational data beneath it, so their customers can move from question to evidence without the usual barriers.”

About Atropos Health

Atropos Health is closing medicine's most consequential gap: actionable insights to inform the vast majority of clinical decisions that are made without evidence. By generating real-world evidence from actual patient outcomes and data, Atropos Health is building the evidence infrastructure that clinicians, life science researchers, and AI platforms need to practice, develop, and inform medicine, grounded in what actually works. Better healthcare is only possible with evidence, and Atropos Health is working to make it available for every patient, in every healthcare decision, every day. Atropos Health does this via GENEVA OS®, the operating system across a robust network of real-world data; Alexandria®, the world’s largest evidence library; and evidence generation tools such as ChatRWD®, Green Button®, and the Atropos Evidence™ Agent.

To learn more about Atropos Health, visit atroposhealth.com or connect through LinkedIn or X (Twitter).

Atropos Health


Release Versions

More News From Atropos Health

Clinical LLM Performance Improves by >300% When Provided With High-Quality Real-World Evidence in New Precision Medicine Benchmark

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, the world’s largest creator of real-world evidence (RWE) for clinical decision support, today introduced Precision Evidence Bench, a first-of-its-kind Precision Medicine Benchmark to evaluate large language models’ (LLMs’) performance against clinical questions grounded in patient context and inclusive of patient history. This Precision Benchmark evaluates how well LLMs are able to provide evidence-based answers that match the specific patient...

Health Universe Partners with Atropos Health to Bring Trusted Real-World Evidence Directly into Clinical Workflows

PALO ALTO, Calif.--(BUSINESS WIRE)--Health Universe, the secure operating environment for agentic healthcare, today announced a partnership with Atropos Health, the world’s largest creator of real-world evidence (RWE) for clinical decision making. Through the partnership, healthcare organizations using Health Universe will gain seamless access to Atropos Health's clinical decision support capabilities directly within the platform, enabling clinicians to incorporate high-quality, patient-specifi...

Atropos Health Has 12 New Peer-Reviewed Research Studies Across Numerous Disease States Published in First Half of 2026

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, the world’s largest creator of real-world evidence (RWE) for clinical decision making, today announced that it has contributed to 12 new studies in the first six months of 2026, powered by high-quality real-world data from the Atropos Evidence™ Network and Atropos Health’s AI-driven real world evidence tools. This new collection of research and conference presentations spans multiple disease states and demonstrates how real-world evidence acce...
Back to Newsroom